[1] |
Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus⁃like DNA sequences in AIDS⁃associated Kaposi′s sarcoma[J]. Science, 1994,266(5192):1865⁃1869. doi: 10.1126/ science.7997879.
|
[2] |
Cesarman E, Chadburn A, Rubinstein PG. KSHV/HHV8⁃mediated hematologic diseases[J]. Blood, 2022,139(7):1013⁃1025. doi: 10.1182/blood.2020005470.
|
[3] |
Bennett SJ, Yalcin D, Privatt SR, et al. Antibody epitope profiling of the KSHV LANA protein using VirScan[J/OL]. PLoS Pathog, 2022,18(12):e1011033. doi: 10.1371/journal.ppat.1011033.
|
[4] |
Luo T, Pan Y, Liu Y, et al. LANA regulates miR⁃155/GATA3 signaling axis by enhancing c⁃Jun/c⁃Fos interaction to promote the proliferation and migration of KSHV⁃infected cells[J]. J Med Virol, 2023,95(1):e28255. doi: 10.1002/jmv.28255.
|
[5] |
Tan M, Li S, Juillard F, et al. MLL1 is regulated by KSHV LANA and is important for virus latency[J]. Nucleic Acids Res, 2021,49(22):12895⁃12911. doi: 10.1093/nar/gkab1094.
|
[6] |
Combs LR, Spires LM, Alonso JD, et al. KSHV RTA induces degradation of the host transcription repressor ID2 to promote the viral lytic cycle[J]. J Virol, 2022,96(12):e0010122. doi: 10.1128/jvi.00101⁃22.
|
[7] |
Di C, Zheng G, Zhang Y, et al. RTA and LANA competitively regulate let⁃7a/RBPJ signal to control KSHV replication[J]. Front Microbiol, 2021,12:804215. doi: 10.3389/fmicb.2021.80 4215.
|
[8] |
Mamimandjiami AI, Mouinga⁃Ondémé A, Ramassamy JL, et al. Epidemiology and genetic variability of HHV⁃8/KSHV among rural populations and Kaposi′s sarcoma patients in Gabon, central Africa. Review of the geographical distribution of HHV⁃8 K1 genotypes in Africa[J]. Viruses, 2021,13(2):175. doi: 10. 3390/v13020175.
|
[9] |
Choi UY, Lee JJ, Park A, et al. Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis[J]. Proc Natl Acad Sci USA, 2020,117(14):8083⁃8093. doi: 10.1073/pnas.191860 7117.
|
[10] |
Tamanaha⁃Nakasone A, Uehara K, Tanabe Y, et al. K1 gene transformation activities in AIDS⁃related and classic type Kaposi′s sarcoma: correlation with clinical presentation[J]. Sci Rep, 2019,9(1):6416. doi: 10.1038/s41598⁃019⁃42763⁃0.
|
[11] |
Samarina N, Ssebyatika G, Tikla T, et al. Recruitment of phospholipase Cγ1 to the non⁃structural membrane protein pK15 of Kaposi sarcoma⁃associated herpesvirus promotes its Src⁃dependent phosphorylation[J/OL]. PLoS Pathog, 2021,17(6):e1009635. doi: 10.1371/journal.ppat.1009635.
|
[12] |
Abere B, Mamo TM, Hartmann S, et al. The Kaposi′s sarcoma⁃associated herpesvirus(KSHV) non⁃structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target[J/OL]. PLoS Pathog, 2017,13(9):e1006639. doi: 10.1371/journal.ppat.1006639.
|
[13] |
吴秀娟, 普雄明, 吴卫东. 人类疱疹病毒8型ORF26基因亚型与Kaposi肉瘤的相关性研究[J]. 中华皮肤科杂志, 2008,41(11):732⁃735. doi: 10.7666/d.Y1375481.
|
[14] |
Wang Y, Nie C, Zang T, et al. Predicting circRNA⁃disease associations based on circRNA expression similarity and functional similarity[J]. Front Genet, 2019,10:832. doi: 10. 3389/fgene.2019.00832.
|
[15] |
Abere B, Li J, Zhou H, et al. Kaposi′s sarcoma⁃associated herpesvirus⁃encoded circRNAs are expressed in infected tumor tissues and are incorporated into virions[J]. mBio, 2020,11(1):e03027⁃19. doi: 10.1128/mBio.03027⁃19.
|
[16] |
Wen Z, Li W, Fang Y, et al. Prevalence and risk factors of Kaposi′s sarcoma⁃associated herpesvirus infection among Han and Uygur populations in Xinjiang, China[J]. Can J Infect Dis Med Microbiol, 2021,2021:2555865. doi: 10.1155/2021/2555865.
|
[17] |
García⁃Cisneros S, Sánchez⁃Alemán MÁ, Conde⁃Glez CJ, et al. Performance of ELISA and Western blot to detect antibodies against HSV⁃2 using dried blood spots[J]. J Infect Public Health, 2019,12(2):224⁃228. doi: 10.1016/j.jiph.2018.10.007.
|
[18] |
Engels EA, Whitby D, Goebel PB, et al. Identifying human herpesvirus 8 infection: performance characteristics of serologic assays[J]. J Acquir Immune Defic Syndr, 2000,23(4):346⁃354. doi: 10.1097/00126334⁃200004010⁃00011.
|
[19] |
Corgiat M, Calvez V, Marcelin AG, et al. Methods comparison for molecular diagnosis of human herpesvirus 8 infections[J]. J Clin Virol, 2020,126:104308. doi: 10.1016/j.jcv.2020.104308.
|
[20] |
Biatougou NM, Ouedraogo MS, Soubeiga ST, et al. Molecular epidemiology of human herpes virus type 8 among patients with compromised immune system in Ouagadougou, Burkina Faso[J]. HIV AIDS(Auckl), 2022,14:311⁃317. doi: 10.2147/HIV.S353166.
|
[21] |
Lopes AO, Lima L, Tozetto⁃Mendoza TR, et al. Low prevalence of human gammaherpesvirus 8(HHV⁃8) infection among HIV⁃infected pregnant women in Rio De Janeiro, Brazil[J]. J Matern Fetal Neonatal Med, 2021,34(20):3458⁃3461. doi: 10.1080/14767058.2019.1685967.
|
[22] |
Kenmoe S, Vernet MA, Penlap Beng V, et al. Phylogenetic variability of human metapneumovirus in patients with acute respiratory infections in Cameroon, 2011⁃2014[J]. J Infect Public Health, 2020,13(4):606⁃612. doi: 10.1016/j.jiph.2019. 08.018.
|
[23] |
Gomez⁃Martinez J, Foulongne V, Laureillard D, et al. Near⁃point⁃of⁃care assay with a visual readout for detection of HIV⁃1 drug resistance mutations: a proof⁃of⁃concept study[J]. Talanta, 2021,231:122378. doi: 10.1016/j.talanta.2021.122378.
|
[24] |
Kury C, Guimaraes GR, Leandro CG, et al. Associations of human papillomavirus(HPV) genotypes and related risk factors in a cohort of women living with HIV in a Brazilian countryside city[J]. J Med Virol, 2022,94(6):2802⁃2810. doi: 10.1002/jmv.27582.
|
[25] |
Mou X, Sheng D, Chen Z, et al. In⁃situ mutation detection by magnetic deads⁃probe based on single base extension and its application in genotyping of hepatitis B virus pre⁃C region 1896nt locus single nucleotide polymorphisms[J]. J Biomed Nanotechnol, 2019,15(12):2393⁃2400. doi: 10.1166/jbn.2019. 2862.
|
[26] |
Hulaniuk ML, Corach D, Trinks J, et al. A simple and rapid approach for human herpesvirus type 8 subtype characterization using single base extension[J]. Lett Appl Microbiol, 2021,73(3):308⁃317. doi: 10.1111/lam.13515.
|
[27] |
Hu T, Chitnis N, Monos D, et al. Next⁃generation sequencing technologies: an overview[J]. Hum Immunol, 2021,82(11):801⁃811. doi: 10.1016/j.humimm.2021.02.012.
|
[28] |
Pai JA, Satpathy AT. High⁃throughput and single⁃cell T cell receptor sequencing technologies[J]. Nat Methods, 2021,18(8):881⁃892. doi: 10.1038/s41592⁃021⁃01201⁃8.
|
[29] |
Zhou K, Xu J, Shang Z, et al. Case report: metagenomic next⁃generation sequencing can contribute to the diagnosis and treatment of disseminated visceral Kaposi sarcoma following allogeneic haematopoietic stem cell transplantation[J]. Front Oncol, 2022,12:848976. doi: 10.3389/fonc.2022.848976.
|
[30] |
Nalwoga A, Webb EL, Muserere C, et al. Variation in KSHV prevalence between geographically proximate locations in Uganda[J]. Infect Agent Cancer, 2020,15:49. doi: 10.1186/s13027⁃020⁃00313⁃8.
|
[31] |
Lee YM, Hung PS, Lin CW. Seroepidemiology and phylogenetic analysis of human herpesvirus type 8 in injection drug users and men who have sex with men in northern Taiwan[J]. J Int Med Res, 2020,48(1):3000605 18764747. doi: 10.1177/0300060518 764747.
|
[32] |
Jary A, Leducq V, Desire N, et al. New Kaposi′s sarcoma⁃associated herpesvirus variant in men who have sex with men associated with severe pathologies[J]. J Infect Dis, 2020,222(8):1320⁃1328. doi: 10.1093/infdis/jiaa180.
|
[33] |
Piselli P, Taborelli M, Cimaglia C, et al. Decreased incidence of Kaposi sarcoma after kidney transplant in Italy and role of mTOR⁃inhibitors: 1997⁃2016[J]. Int J Cancer, 2019,145(2):597⁃598. doi: 10.1002/ijc.32098.
|
[34] |
Marashi SM, Mostafa A, Shoja Z, et al. Human herpesvirus 8 DNA detection and variant analysis in patients with multiple sclerosis[J]. Virusdisease, 2018,29(4):540⁃543. doi: 10.1007/s13337⁃018⁃0481⁃1.
|
[35] |
Gómez I, Pérez⁃Vázquez MD, Tarragó D. Molecular epidemiology of Kaposi sarcoma virus in Spain[J/OL]. PLoS One, 2022,17(10):e0274058. doi: 10.1371/journal.pone.0274058.
|